Form EFFECT Indaptus Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 17, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TUSK Practice Sales: Q3 2026 Dermatology Market Report Finds Private Equity Demand Remains Strong For Dermatology Practices
- FCPT Announces Upsizing and Extension of Unsecured Credit Facility
- Dismissal of EZ LYNK Lawsuit is a Win for Drivers and Right-to-Repair
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
